S100B serum levels are closely correlated with body mass index: An important caveat in neuropsychiatric research

Psychoneuroendocrinology

Volumn 35, Issue 2, 2010, Pages 321-324

  Steiner, Johann ^a   Schiltz, Kolja ^a   Walter, Martin ^a   Wunderlich, Michael T ^a   Keilhoff, Gerburg ^a   Brisch, Ralf ^a   Bielau, Hendrik ^a,b   Bernstein, Hans Gert ^a   Bogerts, Bernhard ^a   Schroeter, Matthias L ^c,d   Westphal, Sabine ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Magdeburg Hospital GmbH   (Germany)

^c MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Adipose derived hormones; Adipose tissue; Fatty acid binding protein; Leptin; S 100B; S100B

Indexed keywords

FATTY ACID BINDING PROTEIN 4; LEPTIN; PROTEIN S100B;

ADIPOSE TISSUE; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL DISEASE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; BODY SIZE; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROPSYCHOLOGY; OBESITY; RESEARCH DESIGN; S100 PROTEINS; YOUNG ADULT;

EID: 73949142356     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.07.012     Document Type: Article

References (15)

1. Casey D.E. Metabolic issues and cardiovascular disease in patients with psychiatric disorders. Am. J. Med. 118 Suppl. 2 (2005) 15S-22S
2. Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell Biol. 33 (2001) 637-668
3. Ehrlich S., Salbach-Andrae H., Weiss D., Burghardt R., Goldhahn K., Craciun E.M., Franke L., Uebelhack R., Klapp B.F., and Lehmkuhl U. S100B in underweight and weight-recovered patients with anorexia nervosa. Psychoneuroendocrinology 33 (2008) 782-788
4. Geroldi D., Falcone C., and Emanuele E. Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target. Curr. Med. Chem. 13 (2006) 1971-1978
5. Holtkamp K., Buhren K., Ponath G., von Eiff C., Herpertz-Dahlmann B., Hebebrand J., and Rothermundt M. Serum levels of S100B are decreased in chronic starvation and normalize with weight gain. J. Neural Transm. 115 (2008) 937-940
6. Leite M.C., Galland F., Brolese G., Guerra M.C., Bortolotto J.W., Freitas R., Almeida L.M., Gottfried C., and Goncalves C.A. A simple, sensitive and widely applicable ELISA for S100B: methodological features of the measurement of this glial protein. J. Neurosci. Methods 169 (2008) 93-99
7. Netto C.B., Conte S., Leite M.C., Pires C., Martins T.L., Vidal P., Benfato M.S., Giugliani R., and Goncalves C.A. Serum S100B protein is increased in fasting rats. Arch. Med. Res. 37 (2006) 683-686
8. Rothermundt M., Peters M., Prehn J.H., and Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 60 (2003) 614-632
9. Schroeter M.L., and Steiner J. Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Mol. Psychiatry 14 (2009) 235-237
10. Steiner J., Bernstein H.G., Bielau H., Berndt A., Brisch R., Mawrin C., Keilhoff G., and Bogerts B. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neurosci. 8 (2007) 2 (10 pages)
11. Steiner J., Bernstein H.G., Bielau H., Farkas N., Winter J., Dobrowolny H., Brisch R., Gos T., Mawrin C., Myint A.M., and Bogerts B. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J. Psychiatr. Res. 42 (2008) 868-876
12. Steiner J., Bernstein H.G., Bogerts B., Gos T., Richter-Landsberg C., Wunderlich M.T., and Keilhoff G. S100B is expressed in, and released from. OLN-93 oligodendrocytes: influence of serum and glucose deprivation. Neuroscience 154 (2008) 496-503
13. Steiner J., Walter M., Wunderlich M.T., Bernstein H.G., Panteli B., Brauner M., Jacobs R., Gos T., Rothermundt M., and Bogerts B. A new pathophysiological aspect of S100B in Schizophrenia: potential regulation of S100B by its scavenger soluble RAGE. Biol. Psychiatry 65 (2009) 1107-1110
14. Suzuki F., and Kato K. Inhibition of adipose S-100 protein release by insulin. Biochim. Biophys. Acta 845 (1985) 311-316
15. Zimmer D.B., Song W., and Zimmer W.E. Isolation of a rat S100 alpha cDNA and distribution of its mRNA in rat tissues. Brain Res. Bull. 27 (1991) 157-162